JAK2 mutations are common in MPNs, such as polycythemia vera (PV) (approximately 90%–95%), essential thrombocytopenia (ET) (60%), and primary myelofibrosis (PMF) (approximately 57%) (13–16). The gene discussed is JAK2; the disease is acquired polycythemia vera.